|
BUD13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.898000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.378500E-04 |
| Normal-vs-Stage2 |
6.853200E-01 |
| Normal-vs-Stage3 |
5.307200E-01 |
| Normal-vs-Stage4 |
6.787800E-01 |
| Stage1-vs-Stage2 |
3.735900E-02 |
| Stage1-vs-Stage3 |
3.66090000000208E-05 |
| Stage1-vs-Stage4 |
5.170800E-04 |
| Stage2-vs-Stage3 |
3.779600E-01 |
| Stage2-vs-Stage4 |
4.798000E-01 |
| Stage3-vs-Stage4 |
8.789800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.605230E-01 |
| Normal-vs-AfricanAmerican |
3.020400E-02 |
| Normal-vs-Asian |
4.333700E-02 |
| Caucasian-vs-AfricanAmerican |
1.190200E-01 |
| Caucasian-vs-Asian |
2.244000E-01 |
| AfricanAmerican-vs-Asian |
7.062400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.527800E-01 |
| Normal-vs-Female |
4.664600E-03 |
| Male-vs-Female |
1.357560E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.851800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.049600E-02 |
| Normal-vs-Age(61-80Yrs) |
2.277200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.546000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.904600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.008000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.552200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.774630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.963030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.332400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.74429999835846E-08 |
| Normal-vs-Grade 2 |
3.027900E-04 |
| Normal-vs-Grade 3 |
8.803800E-01 |
| Normal-vs-Grade 4 |
1.928630E-01 |
| Grade 1-vs-Grade 2 |
2.595900E-03 |
| Grade 1-vs-Grade 3 |
7.33150000042926E-07 |
| Grade 1-vs-Grade 4 |
4.35439999946219E-07 |
| Grade 2-vs-Grade 3 |
1.78441999999501E-05 |
| Grade 2-vs-Grade 4 |
2.08039999999299E-05 |
| Grade 3-vs-Grade 4 |
1.938430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.61199999995743E-06 |
| Normal-vs-ccB subtype |
1.701040E-01 |
| ccA subtype-vs-ccB subtype |
4.34190461362505E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.841830E-01 |
| Normal-vs-N1 |
5.525600E-01 |
| N0-vs-N1 |
2.296400E-01 |
|
|
